Skip to main content
. 2021 May 28;28(5):1062–1071. doi: 10.1007/s12282-021-01241-0

Table 4.

PIK3CA mutation sites in ER-positive breast cancers patients (n = 19), as detected through the Sanger method

Wnt5a expression (IHC) PIK3CA mutation P-value
Exon 9 Exon 20
E542K E545K H1047R
Wnt5a-negative 0 6 4
Wnt5a-positive 1 3 5 0.50

IHC immunohistochemistry